Search

everythinglearnresearchcommunity

for

Search:↓

The research provides insights into hair follicle growth in forest musk deer by identifying key genes and pathways involved.

New cancer treatments are less harmful to hair but can still cause hair loss, color, shape, and growth changes.

Neuregulin3 affects cell development in the skin and mammary glands.

The extract of Silybum marianum, Manganese PCA, and Lespedeza capitata can boost hair growth and extend the growth phase when combined in a serum.

Silybum marianum extract, Manganese PCA, and Lespedeza capitata extract may help with hair growth and anchorage, potentially aiding in hair loss treatment.

Erlotinib causes skin inflammation through IL-1, which can be reduced by anakinra.

Baricitinib successfully treated myasthenia gravis and alopecia in a patient.

Skin reactions from cancer treatments might predict how well the treatments work.

Dexpanthenol helps human hair follicle cells grow by preventing aging and death, and by supporting growth signals.

EGFR helps control how hair grows and forms without needing p53 protein.

A 15-year-old girl with no menstrual period was diagnosed with a genetic condition that makes her body unable to respond to male hormones, leading to female characteristics despite having male genetic makeup.

High levels of ERK activity are key for tissue regeneration in spiny mice, and activating ERK can potentially redirect scar-forming healing towards regenerative healing in mammals.

A protein called desmoglein 3 is important for keeping hair follicle stem cells inactive and helps in their regeneration.

Sorafenib helps some advanced cancers alone or with other treatments, but not all, and research continues to improve its use.

Gefitinib can cause skin problems, diarrhea, and nausea, but rarely causes severe lung disease or hair loss.

Nerves and chemicals in the body can affect hair growth and loss.

Brain-Derived Neurotrophic Factor (BDNF) slows down hair growth and promotes hair follicle regression.

Hair follicles in people with alopecia have lower levels of a key blood vessel growth protein.

Type I interferons play a key role in the development of various skin diseases.

Skin side effects from EGFR inhibitor cancer treatment can be managed effectively, often without stopping the medication.

Spironolactone may make some cancer treatments more effective by blocking a protein that helps cancer cells survive.

Drugmakers are optimistic about targeting the Wnt pathway for new treatments despite past challenges.

Only skin melanocytes, not other types, can color hair in mice.

The research found ways to activate melanocyte stem cells for potential treatment of skin depigmentation conditions.

A cancer patient developed a type of hair loss after starting a cancer drug called vandetanib.

Removing Sprouty genes in mice causes various hormone-related issues but does not increase cancer risk by one year of age.

Adverse events in lung cancer treatments increase fear, anxiety, and depression, with newer therapies causing fewer side effects.

MPA increases cancer spread by boosting Eph A2 activity.

ATP helps prevent skin damage from vandetanib by reducing stress.

Tofacitinib helped regrow hair in most patients with severe hair loss.